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ABSTRACT
The roles that rapid, point-of-care tests will play in healthcare in low-
income settings are likely to expand over the coming years. Yet, very
little is known about how they are incorporated into practice, and
what it means to use and rely upon them. This paper focuses on
the rapid diagnostic test for malaria (mRDT), examining its
introduction into low-level public health facilities in Tanzania
within an intervention to improve the targeting of costly malaria
medication. We interviewed 26 health workers to explore how a
participatory training programme, mobile phone messages,
posters and leaﬂets shaped the use and interpretation of the test.
Drawing on notions of biopolitics, this paper examines how
technologies of the self and mechanisms of surveillance bolstered
the role mRDT in clinical decision-making. It shows how the
signiﬁcance of the test interacted with local knowledge, the
availability of other medication, and local understandings of good
clinical practice. Our ﬁndings suggest that in a context in which
care is reduced to the provision of medicines, strict adherence to
mRDT results may be underpinned by increasing the use of other
pharmaceuticals or may leave health workers with patients for
whom they are unable to provide care.
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Introduction
The lack of diagnostic tools in Africa has been identiﬁed as a central deﬁciency in the pro-
vision of healthcare on the continent (Okeke, 2011). Investment in developing new diag-
nostic tools is seeking to shift this trend and rapid point-of-care (POC) tests provide
particular appeal. Easy to use, they are expected to enable swift diagnosis, without the
necessity of signiﬁcant investment in training, equipment or infrastructure associated
with the development of laboratories (English et al., 2014; Jani & Peter, 2013; Mabey
et al., 2012; Peeling & Mabey, 2010). POC tests are currently available for a number of
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infections (HIV, malaria and chlamydia, syphilis, typhoid) and others are expected to
come into use over the next decade (Jani & Peter, 2013).
This paper is concerned with the introduction of the rapid diagnostic test for malaria
(mRDT). Historically, malaria was treated presumptively but research published in 2004
raised concerns that this was leading to its over-diagnosis, the over-prescription of malaria
medication, and the under-diagnosis of other infections (Reyburn et al., 2004). The intro-
duction of a new, ﬁrst-line therapy, artemisinin combination therapy (ACT), made the
introduction of targeted treatment appear more urgent. ACTs are costly drugs but also
in need of protection from emerging drug resistance, considered by some to be promoted
by the over-prescription of medicine (Aung et al., 2015). The introduction of a highly
accurate, easy-to-use rapid diagnostic test appeared as a practical solution to urgent pro-
blems of poor case management, increasing costs of medication, long-term underinvest-
ment in laboratories and anti-microbial resistance.
Despite their considerable promise in global policy discourse, the results of the initial
studies of the introduction of mRDTs in clinical settings in Africa were marked by disap-
pointment. Tests were often left unused and on the occasions when they were carried out,
patients with a negative test result were often treated for malaria (Bisofﬁ, Gobbi,
Angheben, & Van den Ende, 2009; Reyburn et al., 2007). With much resting on the
promise of the test to reduce the use the ACTs, a number of different training strategies
were implemented and evaluated under trial conditions to try to increase the uptake of the
mRDT and promote its use in providing a deﬁnitive diagnosis of malaria (Odaga et al.,
2014). Several studies on their introduction have focused on the extent to which health
workers will rely on mRDTs to guide decision-making through elicitation of an ‘adher-
ence’ to guidelines outcome (Ansah et al., 2010; Mbacham et al., 2014). Little is known,
however, about the signiﬁcance that these tests hold for daily practices within clinics
beyond their ability to direct (or not) the use of medication.
This paper provides an account of the effects of the tests on everyday practices in
primary care settings in Tanzania as they were implemented during the Targeting Artemi-
sinin Combination Therapy (TACT) intervention trial. Through a bio-political lens, the
paper explores the work entailed in adhering to test results and the new regimes of treat-
ment that they imply. It analyses the ways in which changes in prescribing practices were
managed in the context of pre-existing socio-material relationships and moral frameworks
in the clinic; and how powerful dilemmas could emerge when new policy went against
understandings of good care already in place.
Conceptualising mRDTs
In much of the literature on mRDTs, the test is conceptualised as an ‘autonomous deter-
mining force’ (Schubert, 2011) with a single role to play in the clinical encounter and with
the impact of its introduction distinguishable by its intended and unintended conse-
quences. In this paper, we shift the focus to incorporate the broad and sometimes contra-
dictory effects of the test as part of its emergent, relational nature as a (health) tool, the
signiﬁcance of which is ultimately contingent upon the objects, people and social relations
within which it is embedded (Rock, Degeling, & Blue, 2013). We understand the TACT
trial as ﬁeld of social practice (Pool & Geissler, 2005) in which assemblages of technology,
health workers and patients, policy prescription and training practices, and medication
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come together with social relationships and expectations of care (Cohn, Clinch, Bunn, &
Stronge, 2013; Collier & Ong, 2005).
Our main argument revolves around our interpretation of the TACT trial as a project
that intertwined political, social and biological processes as it sought to intervene in the
socio-material relations of health workers, patients and medicines (Prince, 2012; Rose,
2007). It relates therefore to the literature on bio-politics, and to the concerns with the
ways in which biological knowledge and deﬁnitions have become central to our con-
ception of self but (more importantly here) also become the sites upon which governance,
negotiation and debate take place (Prince, 2012; Rose, 2007). Through our analysis, the
TACT trial emerges as site of governmentality. We show how it sought to install a particu-
lar regime of practice (Dean, 1999 (2010)) through attempts to craft new subjectivities
among health workers (through learning and practicing technologies of the self); by
putting in place mechanisms of surveillance and establishing the role of the mRDT as a
technical mode of truth telling (Foucault, 2011).
Like others drawing on Foucault and bio-political frames to analyse health in East
Africa, however, we do not see this intervention as a perfectly implemented, ‘seamless
bio-political disciplining project’ (Geissler, Rottenburg, & Zenker, 2012). Rather we
show how the trial’s ability to govern medicine and extend power into the facility was
limited, and we explore how the TACT trial, as a form of governmentality, played out
in spaces in which the relationships between health workers, patients and medicines
were also shaped by other forms of care and moralities (Marsland & Prince, 2012). Our
work, therefore, speaks to the literature on the locally embedded nature of decision-
making around treatment that takes into account the results of technical investigations,
but is also contingent upon knowledge about a patient’s economic and social situation;
relationships between clinicians and patients; and local possibilities for treatment
(Armstrong & Hilton, 2014; Mol, 2003; Mol & Law, 1994; Street, 2011). We show that
while the trial envisaged the mRDT as a tool to be adhered to, local knowledge often chal-
lenged its signiﬁcance in the clinical encounter.
The TACT trial
The TACT trial was constructed to evaluate the effect of small group, participatory train-
ing and the use of communication tools on the uptake of mRDTs and on the prescription
of ACTs in low-level public sector facilities in Tanzania (Chandler et al., 2014). It com-
prised three arms: the control arm, the health worker arm (hereafter HW arm) and the
health worker patient arm (hereafter HWP arm). The control arm was based entirely
on the Tanzanian Ministry of Health’s two-day mRDT didactic, classroom-based training
programme that was being implemented at the time. It relied upon a learner manual and
practical guide (a job aid) with a short facility-based practical session. In the HW arm and
HWP, health workers also received this government training. In addition, both groups
were provided with three extra sessions that were described as teaching participants
how to adapt to using mRDTs, how to use an mRDT with conﬁdence and how to
sustain these changes in practice. It provided copies of research papers about mRDTs;
encouraged health workers to experiment with mRDTs by observing the impact of
restricting prescriptions of ACTs to those with mRDT-positive results and underscored
the use of mRDTs as part of the practices of a modern health worker. The training
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sought to develop communities of practice (Wenger, 1998) and emphasised shared learn-
ing. It also developed health worker skills of managing patients in the process of instituting
this change (Figure 1).
Following the training in the HW and the HWP arms of the trial, a series of SMS texts
were sent to reinforce the messages provided in the training with the aim of motivating
health workers by providing feedback on their performance, and messages that encour-
aged the use of mRDTs. In addition, both HW and HWP arms received a poster
setting out that fevers encompass more than malaria and that they should trust the test.
In the HWP arm of the trial a pictorial, story-based patient leaﬂet was provided, setting
out that mRDTs are available; why mRDTs are trustworthy; encouraging patients to
experiment in not taking anti-malarials after negative test results; and that health
workers should give information to patients. This was expected to provide a model for
good practice, and give support to health workers in communicating results and treatment
decisions to patients who suspected they had malaria.
Research methods
Embedded within the TACT trial was a qualitative study to explore the health workers’
response to the training and the intervention as a part of the overall evaluation of the
trial. The research comprised 26 face-to-face, in-depth interviews with health workers
at six months (n = 10) and at 18 months after the trial began (n = 16). The majority of
the interviews were conducted six months after the trial had closed, allowing space for
critical reﬂection of the trial and enabling interviews to be undertaken when the trial
no longer had any formal power over the participants. At both time points, the majority
of interviews were undertaken in the intervention arms of the trial (HW and HWP),
Figure 1. TACT trial – interviews.
1080 E. HUTCHINSON ET AL.
reﬂecting the researchers’ interest in providing an in-depth analysis of the relationships
between the different elements of the trial and the shaping of practice.
The research participants were identiﬁed through the TACT trial records. The
inclusion criteria were health workers who regularly prescribed anti-malarial treatment
at the health facility and who had attended training on mRDTs in 2011. Participants
were selected purposively to incorporate different cadres and include good and poor per-
formers in terms of uptake and adherence to mRDTs. Neither interviewer nor interpreter
was aware of who were better or worse performers during the interview and none of the
participants were interviewed at both 6 and 18 months. Participants were invited to par-
ticipate by the TACT trial ﬁeld research team, and asked for written consent before the day
of the interview and verbal consent and agreement to tape recording on the day.
The interviews were mostly conducted in English or in a mix of English and Swahili
(with the exception of one in the health worker arm at six months, conducted entirely
in Swahili) by interviewers who were not members of the TACT trial team. This was a
deliberate choice on the part of the interviewers to enable the interviewees to express them-
selves as effectively and ﬂuidly as possibly. A bilingual social scientist (a member of the
TACT study team) was present at each of the interviews to provide a meaning-based trans-
lation when the need arose. The translator was given the space to check her translation
with the informant whenever she was unsure of the meaning of their conversation.
The interviews began with introductions that underscored the importance of speaking
freely about the test and the trial, and that the interviews were not a form of assessment.
The ﬁrst set of questions revolved around the most signiﬁcant change that the health
workers had experienced in the dispensary in the recent past, a method developed to gen-
erate detailed qualitative descriptions of interventions in low-income settings (Dart &
Davies, 2003). The interviewer had a list of additional prompting questions about what
the changes were, how they were made and why they were important to the participant
(Dart & Davies, 2003). This was supplemented with further questions about the health
workers’ experiences of and practices around the different elements of the trial (the test,
the training, the SMS messages, the poster and the leaﬂet). It ended with a question
about whether or not they trusted the mRDT and a series of questions about speciﬁc
occasions when they had thought that the test result was wrong and how the situation
had been managed.
At six months, only the English language translations were transcribed, a considerable
limitation of the study. At 18 months the interviews were transcribed and translated in full.
The initial analysis of the data was undertaken by the interviewers, under the supervision
of an anthropologist to provide a descriptive account of the impact of the different
elements of the trial. A second round of analysis was then performed, relying on both
theory-driven and inductive analytic strategies that form the basis of this paper.
Ethical clearance
The study was approved by the Ethical Review Boards of the National Institute for Medical
Research in Tanzania and the London School of Hygiene and Tropical Medicine
(LSHTM) (NIMRlHQ/R.8cNol. 11/24 and #5877, respectively). The trial was registered
with clinicaltrials.gov (Identiﬁer # NCT01292707) and was subject to external monitoring
from LSHTM to ensure adherence with the protocol.
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Results and discussion
Narratives of change: aligning with evidence-based medicine
Most health workers interviewed at both 6 and 18 months described a process of care-
giving in their clinics as one that was expected to end in the prescription of medicines
or on occasion the referral of patients to another clinic or hospital. Explaining how
mRDTs impact on these practices, health workers pointed to shifts in prescribing patterns,
switching treatments, and referring patients for further tests. Few described the mRDT as
enabling them to make better diagnostic decisions (often described of as thinking of
further problems). Of those that did, one described the introduction of mRDTs as
having put pay to a trend in which patients failing to recover from their illness would
return multiple times to a clinic to be treated each time with malaria medication.
Health workers across all the arms of the trial were well-versed in the political economy
of the mRDT, and the beneﬁts that they had for government expenditure. During the
interviews, health workers often aligned themselves with these aims of the test’s introduc-
tion as it was set out in the training, in some cases perhaps perceiving that this was what
was hoped for by the interviewers. Past practices around the provision of care and medi-
cation for patients cast as both random and wasteful and a threat to the efﬁcacy of the
drugs. Some health workers developed the narrative of the training, stating that previous
practices were dangerous and had ‘destroyed’ patients’ lives. Across all arms of the trial at
both 6 and 18 months, the description of the use of the new diagnostic tool was, in con-
trast, presented in language that foregrounded global and national policy concerns and
discourse: that they are economic, (disease) speciﬁc and proper, with the use of the
mRDT emerging as a moral issue.
R: Now we treat patients thoroughly. We don’t prescribe using clinical signs and symptoms
as we were previously.
I: And you are happy with that?
R: Yes, because we were using a lot of medicine but now we just use a small amount of Alu
[ACT] and this is an economic beneﬁt for our country for all sections all health facilities using
that procedure. We were using a lot of drugs unnecessarily.
Clinical Ofﬁcer, Control arm at 18 months
Yet, the narrative in the training did not simply work as a new morality in the practice of
prescribing medicines. Health workers were able to map their role in the governance of
medicines. The narrative below, for example, makes connections between their clinical
history-taking, using an mRDT, making decisions around medicines and the activities
of the government. It also served to make practices in the clinic an issue of saving and
redistributing the government health budget.
Previously it was, when a patient came to the facility, if they had a fever, we would prescribe
an antimalarial. We would not discuss their symptoms with them or ask any questions. But
now we are not using them so much. If you go back and look at our ordering system we were
using the anti-malarials and then we were ordering a lot of drugs. When they were ﬁnished
and we ordered more and then they were ﬁnished. But now, we have discovered that we order
very few antimalarial drugs. And this will help in the government budget so that the budget
that was used for these drugs can go somewhere else.
Clinical Ofﬁcer, HWP arm at six months
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Practicing change: changing the (professional) self
Fashioning previous practices around the diagnosis of malaria in the clinics as random,
wasteful and dangerous and the new way of diagnosing malaria as scientiﬁc and
modern was part of a process in which the TACT trial sought to ﬁx the interpretation
of the relevance and position of the mRDT in the everyday practice at the health facilities.
In so doing, the training presented the mRDT as a representation of modern biomedicine
and those who used it as modern clinicians in opposition to traditional doctors who con-
tinued to use signs and symptoms. The TACT training supplemented this with a number
of journal articles that set the mRDT in its intellectual, scientiﬁc context. Yet, health
workers in the intervention arms of the trial were not expected to simply learn and
read about biomedical knowledge. The intervention’s conceptualisation rested on the
notion that early adopters of mRDTs were able to experiment with restricting access to
malaria medication on receipt of a negative mRDT result (Chandler et al., 2014). Under
the trial, health workers were encouraged to reproduce the new knowledge that they
had learned in the training within their health facilities: new rules were expected to be
internalised through new regimes of observational practices when a particular medical
gaze (and economic framework) was turned on both themselves and on their patients
(Foucault, 1994). Health workers reported that experimenting with the test by restricting
their own access to malaria medication and observing whether they would recover without
taking an ACT had a powerful effect on their behaviour. For example,
I was feeling very feverish and then I decided maybe to teach myself. I asked the other health
worker to test me with the RDT so that I could see how it reacted. So, I was tested and it was
negative and I said, ‘I have to follow what the training taught so that I can see if it works on
me or not.’ So, I said, ‘so long as it is negative then I will just use the amoxicillin and pain
killers,’ something like that. So, I rested for ﬁve days and the fever went and from there I
said, ‘No, I should not be taking the antimalarial,’ and I have not taken an antimalarial
since then.
Clinical ofﬁcer, HWC arm at six months
Although health workers did not always deﬁne this as a successful process, these
changes in and observations of their own practices were mostly articulated as positive
experiences that powerfully reafﬁrmed the lessons learned in the training, changing the
ways in which they understood their own sickness and use of malaria medication.
Incorporating the test into practice: the care value of drugs
While theTACT trial (following government policy)made demands that themRDTbecome
the sole tool upon which a decision about treatment for malaria would be made, the test
results were often incorporated into a broader decision-making process which also relied
on other sources of knowledge. Health workers, while keen to use the test, also incorporated
concerns about patients who failed to recover after several visits to the health facility,
patient’s interpretations of their illness, clinical signs and symptoms of malaria and a
history of patient’s movement (into an area with high rates ofmalaria) in the diagnostic pro-
cesses. They also described taking into account patients’ socio-economic status
The patient did not want to be referred because of her responsibilities at home. I gave her an
ACT, an anti-vomiting drug and oral rehydration salts to help her as she told me that
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husband is living far away, she has a small child and no money. (Clinical ofﬁcer, Control arm
at six months)
These considerations had the potential to overwhelm the position of the test in the
clinic as the tool upon which a decision about malaria treatment would be made and
patients with a negative test result would be treated with an ACT.
Health workers who continued to rely upon practical knowledge in order to make
their diagnosis also described times when they had been concerned that the test had
failed due to human error. In these cases, issues around who had conducted the test,
whether there was enough buffer, whether patients had taken other medicine that
might affect results, whether there might have been too much blood in the test, or if
the test read ‘neutral’ shaped the role of the test in the decision-making about treatment,
with some patients with a negative test result being treated with malaria medication.
Importantly, this was not considered by one health worker as an example of not trusting
the test per se, but rather as reﬂecting the uncertainties of the practices around the test in
the clinic:
CO: Personally, I have used an mRDT to test for malaria. It was negative and so I went to
have a test using microscopy. They told me that I had malaria with a 3+ parasite load but
I didn’t take any antimalarial so I think it is accurate.
I: Have you ever thought that may be the test is incorrect?
CO: Yes, it happened when a boy of two years came in with vomiting and fever. I was not the
person who conducted the test (my colleague did it) and I looked at the test I couldn’t agree
with the results.
I: What did you do?
CO: I just gave him an anti-malarial.
I: Why do you think it was negative if you thought he has malaria?
CO: I thought that maybe there had not been enough buffer. I say maybe because I was not
there when he conducted the test.
I: Can you think of the reasons why the test might be incorrect sometimes?
CO: May be someone can put few drops of buffer, I think that is the most (common) thing I
can think of.
Clinical Ofﬁcer, HW arm at 18 months
In some cases, the test emerged as being of most value at the beginning of a consultation,
enabling the health worker to rule in or out malaria at this point. Patients would then be
assessed for other causes of illness and, if none could be found, then the health worker
could return to a diagnosis of malaria. While the efforts to seek an alternative diagnosis
and treatment accords well with a normative model of biomedical care, descriptions of
providing patients with medication demonstrated that it did not simply work as a
means of providing a treatment for an identiﬁable disease. Health workers described a
process of replacing malaria medicine with other drugs with no emphasis laid on
making a diagnosis (‘Whereas previously I could give anti-malarial to every patient
with fever, cough, or body pain, now if the mRDT is negative I will go for an antibiotic.’
Clinical Ofﬁcer, HW arm at 18 months). Others used less powerful medication, describing
how medicines had to be provided in order for care to be experienced.
When the patient comes even if it’s negative, it has to be dealt with carefully. I give placebo, I
can just prescribe paracetamol and B-complex or magnesium so that she or he feels she or he
has come from hospital. For example, if we’ll do as we were taught in the seminar it has to be
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– if it is negative no need to prescribe anything – that will really bring conﬂict especially to us
in rural areas. That is that’s why we are trying to prescribe placebo like B-complex or para-
cetamol because such a person is negative and there is no need to give any other drug – unless
otherwise she or he is presenting with other symptoms you can either consider piriton and
tell him/her how to take it.
Clinical ofﬁcer, HW arm at 18 months
In the face of their new restrictions around malaria medicines, health workers also
became creative, using innovative strategies to enable patients to be satisﬁed with their
care while they also adhered to the policy of the intervention. One clinical ofﬁcer, inter-
viewed at 18 months, refused to replace ACTs with other medicines, repeating and extend-
ing concerns raised by other health workers that using medicines unnecessarily can
‘destroy’ a patient’s health. He described how he combined the test, health education
and the gift of an empty pill container to foster satisfaction and contentment in his
patients who tested negative for malaria, something he considered a critical element of
care-giving. Yet, it was not simply the changes learned in the training that shaped these
new care-giving practices; the receipt of an SMS could work powerfully to mediate
relationships between health workers, patients and (malaria) medicines.
Adhering to the test: SMS as a form of surveillance
The SMS technology used by the trial was designed to impact on provider practice from a
distance (cf. Rose, 2007) and extend the narratives of the training to underpin new prac-
tices associated with it in the clinic. Health workers reported that these texts worked well
by framing the mRDT in the knowledge that they gained in the training and reconnecting
them with the facts that they were presented with – that mRDTs were trustworthy and that
they should use them on all patients with fever and to direct their decision-making about
when to prescribe an ACT. Many health workers described the SMS as having an immedi-
ate effect on their practices within the clinic. This was often not simply a process of
remembering lessons learned but one in which health workers felt that the SMS provided
them with power enabling them, for example, to stand ﬁrm in the face of patient demands
for medication.
Ok, the test said negative, but the patient was complaining a lot. Then I tried to counsel him
but he said, ‘Usually when feel like this I take malaria medication and I get better but without
the drugs I am not getting better.’He did not want to leave. He just sat there insisting I should
write a prescription for a malaria medication. Then, the message came through my phone
and I read it. Then I kept insisting to the patient that I wouldn’t give him the medicine.
Clinical Ofﬁcer, HW arm at 18 months
While the SMS could be interpreted as conferring power onto the health worker, when
health workers wished to act against the results of the test, its signiﬁcance in the clinic
could shift. The combination of an SMS and test result could become a powerful challenge
to the health worker’s decision-making about the best course of action for the patient, with
the power resting with the technology and with those who were providing the tests and the
messages rather than with the health worker. At these moments, the text messages
emerged less as a helpful reminder or device to empower health workers as they
managed patients’ hopes around medicines and more like an unwanted form of surveil-
lance, that made health workers consciousness of the fact that their interaction with
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mRDTs and malaria medication were under scrutiny by those beyond the clinic. This
reconﬁgured the mRDT as a tool that made signiﬁcant demands, creating conﬂict
between older moralities of providing care and newer ones of adhering to results.
CO: Sometimes the SMSs really surprised me. I have treated a patient who tested negative
with an antimalarial but when I receive a text message that saying that I should treat the
patient according to the test result and not according to my feeling, then I feel that I have
done something wrong. Sometimes the patient comes and you test and if it is negative you
give antibiotic for ﬁve days. But, after ﬁve days the patient may come back and say they
are still not feeling well so at that point… . you know the patient is a human. Then the
patient may come like three or more times again in the same situation and you test and it
is negative and so you don’t give an antimalarial. Then, the time that you do give an antima-
larial is the one when you receive an SMS saying ‘treat according to the test result’ and then
you feel like these people are watching me. I remember an example of a woman who was sick.
She had a headache and a fever but the test showed no malaria and I gave her antibiotic for
the cough and paracetamol for her fever. After a week, she came back again and I tested her
and she had no malaria. I told her that she should use painkillers and come back after two
days. Again, she came back with a fever and headache and she asked me to give Alu
because she is not recovering.
I: When you received the message to treat according to the test results did that make you
change what you were doing?
CO: I agree that I have changed but sometimes it is very difﬁcult. It takes me a long time to
give a patient [with a negative test result] an antimalarial.
Clinical Ofﬁcer, HW arm at 18 months
Of signiﬁcance in this discussion is the way in which the clinical ofﬁcer understands the
patient’s desire for medicine as part of their humanity, something that always adhering to
the test result has the potential to undermine.
Adhering to the test: posters, leaﬂets as the justiﬁcation of decision-making
In the HW and HWP arm of the trial, the health workers described the use of the poster
(HW and HWP arm) and the leaﬂet (HWP arm only) as echoing the work of the SMS to
situate the test in the policy framework, bringing facts about the accuracy of mRDTs,
declining rates of malaria in Tanzania and the correct way to treat patients (through
alternative medication and referral) directly into the clinic. For many health workers,
the posters and the leaﬂets were interpreted as effectively providing information about
the change of practice in a clinic, and introducing patients to new forms of treatment.
Some reported that they also relied on them to refresh their own memories of the
correct way to conduct the test. For other health workers, however, concerns with patients’
negative response to or suspicion of the introduction of the mRDT, the leaﬂets and posters
were also being used to provide power to the test results and the health worker by locating
the relationship between the test, the health worker and the patient within government
policy (‘At the beginning the patients thought the tests are ours so we were telling them
to read the poster, that the tests were brought by the government.’ Clinical Ofﬁcer, HW
arm at 18 months), effectively demonstrating that there was a powerful external force
shaping practice around diagnosis and treatment for malaria within the clinic. Yet, the
leaﬂets and the poster did not always work in convincing patients about the need to use
the tests and health workers developed other techniques in the clinic as they managed
the implications of the test results.
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So then I had to use [a] kind of trick that this is the law that is being enforced, that when this
device is positive I have to record that it is positive and then I have to give the antimalarials.
But for now this one doesn’t say that it is positive, then [if] I have to record that I have given
you antimalarial so it’s kind [of], I’m going to be sued. So, I just try to make the patient
understand. So I even told the person, those who are bringing the test are the ones giving
the drugs, so they will question me and I won’t have the way to explain to them why this
happens this way.
Clinical Ofﬁcer, HWP arm at six months
The clinical ofﬁcer above had access to a number of materials that could have helped him
to describe the beneﬁts of parasitological testing to the patient. Yet, his description of the
encounter in the clinic shows how he was left unable to ﬁnd the words to convince the
patient that it was logical that he was relying on the test to make a decision about treat-
ment. Instead, he presented the impossibility of acting against the test to the patient, resi-
tuating its results as a ‘matter of law’ and the role of the health worker as one of acting on
government policy, as an agent of the government rather than a health worker with an
obligation to provide care for the patient.
Conclusions
In this paper, we have analysed the TACT trial as a project that sought to intertwine social
processes (the creation of new identities and relationships between health workers and
patients); political issues (about the relationship between health workers and the govern-
ment) and biological processes (of the treatment and management of diseases) as it sought
to set the role mRDT in public sector clinics. In our analysis, the TACT trial’s processes of
self-observation and experimentation with mRDTs have been presented as a technology of
the self, regulating the use of ACTs as health workers created knowledge about their own
bodies and those of their patients (Foucault, 1990 [1985]). We have shown how the trial
seems to have been most powerful as a form of governance (as described by Foucault in his
later work) as it bundled together these techniques of the self with technologies of surveil-
lance (SMSs, posters and leaﬂets) to underscore the role of the test as a mode of technical
truth telling (Foucault, 2011).
The TACT trial did not always create a substantial shift in these socio-material relations
in the clinics. The test could be incorporated it into practice as part of a decision-making
process that also drew on other, locally produced knowledge and the mRDT’s role in the
clinical encounter could be undermined. It seems likely that these processes are also
underway in other clinics in Tanzania, with results from routine clinical practice in Tan-
zania showing that mRDTs do not dominate as a means of decision-making around
malaria (Bruxvoort et al., 2013). At certain moments, however, processes of self-regulation
and surveillance appeared to be very powerful in the clinic, challenging the social and
moral order primarily around the hopes and sometimes demands for care that is encap-
sulated in the provision of medicine. Health workers who felt unable to prescribe ACTs in
the ways that they wanted described being left unable to respond to the humanity of
patients or having to trick them into accepting new practices. This echoes other work
on self-regulation in other institutional settings in Africa (notably in schools and
among humans rights activists) in which attempts to create new forms of subjectivity in
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some social actors are entangled with practices of objectiﬁcation in others (Englund,
2006).
In this way, the mRDT could appear less a tool that could support a diagnostic process,
and more a tool enabling an economic intervention to save precious medical supplies,
enabling governments to exert considerable control (from a distance) in places that
have traditionally been hard to reach. In addition to their ability to reduce costs associated
with treatment in areas of low prevalence of malaria, it could be that it is this (potential)
role of the mRDT as part of a package of measures to render peripheral spaces governable
that is part of its continued attraction to these tests despite the fact that their impact on
health outcomes has yet to be demonstrated (Beisel, 2014; Odaga et al., 2014).
Overall, the experience of introducing mRDTs in the different arms of the TACT trial
revealed the contingent nature of these tests as a medical tool; that rather than being an
autonomous force (as is often suggested in policy discourse) other objects, processes
and relationships shape their practical signiﬁcance in the health facilities. Over the next
decade, a number of other rapid diagnostic tests are likely to be introduced in low-
income settings and it seems likely that this will be similarly shaped by the contexts in
which they are placed. While the use of other diagnostic tests and processes may not chal-
lenge obligations between health workers and patients in the same way as an mRDT (as
their role may not primarily be about reducing the use of a particular medicine), their
introduction may well shift processes of care-giving, enabling different conﬁgurations of
social and moral order to come into being (Schubert, 2011). If mRDTs and other tests
can be incorporated into practice in a way in which the judicious use and interpretation
of test result could complement clinical decision-making, it may increase the efﬁcacy of
treatment without undermining current care practices. The resolution between the
more ﬂexible and more dogmatic interpretations of the mRDT that we have shown
here may come with improved training of health workers, and through better resourcing
of health facilities, enabling well-trained staff in well-resourced clinics to use test results
critically and in a way that enhances their duty of care.
Strengths and limitations
This qualitative study took place alongside a cluster controlled trial to provide an under-
standing of the broader impacts of introducing rapid diagnostic tests on care-giving pro-
cesses. This adds to the existing literature describing the immediate challenges and
opportunities presented by mRDTs to health workers in Tanzania and elsewhere (Chand-
ler et al., 2008, 2012). Our sampling strategy ensured we included a range of participants in
terms of their use and uptake of the tests under the TACT trial at two different time
frames. Our approach however, is limited in its use of a translator and interviews that
rely on the participants’ own accounts of their practices, as it is possible that their presen-
tation of their use of the test was framed in a particular way during the interviews. More-
over, these interviews could not take into account patient perspectives on the introduction
of the test and patient interpretations of the change in practice around malaria. A different
approach that relied upon participant observation, for example, would have permitted an
analysis of the role of mRDTs in relation to a broader range of practices in the dispen-
saries, and how negotiations between health workers patients are managed over the
uptake and adherence to test results.
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